2025 Future of Pharmacy Showcase

  • Saturday, November 08, 2025
  • 7:30 AM - 1:30 PM
  • University of Rhode Island College of Pharmacy, 7 Greenhouse Rd, Kingston, RI 02881

Registration

  • An opportunity to receive 4 continuing education credits

Register

Rhode Island Society of Health-System Pharmacists Future of Pharmacy Showcase

Saturday, November 8th Starting At 7:30 AM

University of Rhode Island College of Pharmacy
7 Greenhouse Rd
Kingston, RI 02881

7:30 am – 8:00 am    

Registration and Exhibits

8:00 am – 8:30 am Sponsored Breakfast Presentation

8:35 am – 8:40 am

Opening remarks

Kerry LaPlante, PharmD., FCCP, FIDSA, FIDP

Dean, College of Pharmacy University of Rhode Island, Kingston, RI

8:40 am-9:40 am

Future of Pharmacy Showcase: Clinical Pearls (1 contact hour)

Moderator: Conor McGladrigan, PharmD, JD, BCOP, BCSCP

RISHP President

8:40 am -9:00 am

The Sweet Truth About Diabetes Management

Linda Guddie, BSPharm-Blood Glucose Stewardship Pharmacist

Rhode Island Hospital

9:00 am – 9:20 am

A Breath of Fresh Air: Rethinking Inhaled Delivery in the Hospital

Shawn Whitehead, PharmD, BCCP-Inpatient Clinical Pharmacy Manager

Rhode Island Hospital

9:20 am – 9:40 am

Common Medical Devices

Daniel Thifault, PharmD, MBA-MSL Bavarian Nordic and Clinical Pharmacist

Women & Infants Hospital

9:40 am – 10:00 am

Coffee Break and Exhibits

10:00 am-11:30 am

Future of Pharmacy Showcase: Pharmacy Law (1.5 contact hours)

Moderator: Brian Leung, PharmD-Director of Pharmacy

Landmark Medical Center

10:00 am-10:30 am

Keynote Speaker

Bryan McCarthy, PharmD, MS, MJ, FASHP

Legislation to Liberation: What Tech Check Tech Means for You

System Director of Inpatient Pharmacy

Brown University Health

10:30 am-10:45 am

Behind the Bills: RISHP 2025 Legislative Session

Rachel Savoie, PharmD-Clinical Pharmacist

Women & Infants Hospital

10:45 am-11:00 am

Behind the Vote:

A Look Inside ASHP House of Delegates & 2025 Policy Priorities

Karen Nolan, RPh, MBA, DPLA

Director of Inpatient Pharmacy, Rhode Island Hospital

Nelson Caetano, PharmD, MBA, DPLA

Pharmacy Director, The Miriam Hospital

11:00 am-11:30 am

Balancing the Scales:

Inflation Reduction Act, 340b Shifts & State Debates

Karolyn Pattie, PharmD, MBA

Director of Specialty and Retail Pharmacy Operations

Care New England

11:30 am-11:45 am

RISHP Business Meeting

RISHP President: Conor McGladrigan, PharmD, JD, BCOP, BCSCP

11:45 am-12:00 pm Coffee Break and Exhibits
12:00 pm-1:30 pm

Future of Pharmacy Showcase: Patient Safety (1.5 contact hours)

Moderator: Mark Rogers, PharmD, MBA-Director of Pharmacy

Lawrence + Memorial and Westerly Hospital

12:00 pm-12:20 pm

 Hand-off RX: Pharmacists and Technicians

Linking Care Across Settings

Jennifer Wills, PharmD, BCACP-Clinical Pharmacist Specialist

Lawrence + Memorial

12:20 pm-12:40 pm

Emerging Treatment Strategies to Combat Multi-Drug Resistant 

Gram-Negative Infections

Thomas Lavoie, PharmD- Infectious Disease Pharmacotherapy Specialist

Providence Veterans Medical Center

12:40 pm-1:00 pm

Evaluating Outcomes Following the Implementation of an

Electronic Health Record- Embedded Critical Care Infusion Calculator

Darlene Tat, PharmD, MPH-Pharmacy Department Coordinator

(Analytics, Impact and Outcomes)

Brown University Health

1:00 pm-1:30 pm

The Role of Pharmacy Team Members in Preventing

Medication Errors at Discharge: A Discussion and Call to Action

Brian Wegner, PharmD, BCPS- Clinical Pharmacist Specialist

Rhode Island Hospital

1:30 pm-1:35 pm  Closing Remarks
1:35 pm-2:30 pm

Fellowship Panel (25 minutes)

Residency Panel (25 minutes)

CONTINUING EDUCATION CREDITS

The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This educational activity provides 4 live contact hours (0.4 CEUs), including 1.50 contact hours of pharmacy law, to participants who meet the requirements for CE.

UNIVERSAL ACTIVITY NUMBERs (UAN)

Pharmacists UAN: 0060-9999-25-050-L01-P | Pharmacy Technicians UAN:0060-9999-25-050-L01-T  T 1.0 contact hours (0.1 CEUs) Clinical Pearls (Application-based)

Pharmacists UAN: 0060-9999-25-051-L03-P  Pharmacy Technicians UAN: 0060-9999-25-051-L03-T 1.50 (0.15 CEUs) Pharmacy Law (Knowledge-based)

Pharmacists UAN 0060-9999-25-052-L05-P | Technician UAN 0060-9999-25-052-L05-T 1.50 contact hours (0.15 CEUS) Patient Safety (Knowledge-based)

Future of Pharmacy Showcase Learning Objectives (Pharmacists): Upon completion of this activity, pharmacists should be able to:

Clinical Pearls Learning Objectives:

  • Explain how to perform a step-wise approach to standardize diabetes management in the hospital. 
  • Identify pearls about diabetes management for unique patient situations.
  • Describe how to optimize discharge diabetes regimens with noteworthy outpatient considerations.
  • Identify the primary operational, safety, and financial drivers for the inpatient inhaler-to-nebulizer initiative.
  • Describe the key components of the therapeutic interchange program.
  • Analyze the projected impact of the therapeutic interchange program on the health system.
  • Demonstrate how to use a metered dose inhaler (MDI) and a spacer.
  • Demonstrate how to use a titratable pen (e.g., insulin pen).
  • Demonstrate how to use an autoinjector.

Pharmacy Law Learning Objectives:

  • Describe the key provisions of Rhode Island’s recently enacted Tech Check Teck legislation and the advocacy efforts that led to its passage.
  • Assess the potential impact of Tech Check Tech on pharmacy workflow, pharmacist workload, and patient safety within their own practice environments.
  • Identify strategies and operational considerations for implementing Tech Check Tech legislation at their respective institutions.
  • Describe operational and clinical changes to pharmacy practice as a result of new legislation.
  • Describe one new business item that was approved at the 2025 House of Delegates meeting.
  • Describe two policies that were approved at the 2025 House of Delegates meeting
  • Describe the key components and the purpose of the 340B Drug Pricing Program and the Inflation Reduction Act’s Maximum Fair Price provisions.
  • Discuss how state level-legislation (Rhode Island’s 2025 law) and federal policies impact drug pricing, access, and pharmacy operations.
  • Explain the potential operational and compliance implications of 340B changes and MFP pricing structures in health system pharmacy settings.

Patient Safety Learning Objectives:

  • Describe the distinct and overlapping responsibilities of pharmacists and pharmacy technicians.
  • Discuss best practices and tools for obtaining and verifying a complete, accurate medication list during admission and discharge.
  • Identify emerging treatment strategies to combat multi-drug resistant gram-negative infections.
  • Describe the impacts of appropriate antimicrobial stewardship for multi-drug resistant gram-negative infections.
  • Explain how to evaluate patient outcomes related to insulin infusion-related protocol changes in the critical care setting.
  • Describe analytical strategies to evaluate institutional medication-related protocol changes.
  • Describe common causes and consequences of medication errors at hospital discharge.
  • Apply strategies to identify and resolve medication discrepancies through effective reconciliation.
  •  Evaluate opportunities to expand the pharmacist’s role in transitions of care to improve patient safety.

Future of Pharmacy Showcase Learning Objectives (Technicians): Upon completion of this activity, pharmacy technicians should be able to:

Clinical Pearls Learning Objectives:

  •  Explain the elements of a standardized diabetes management program in the hospital.
  •  Identify the primary operational, safety, and financial drivers for the inpatient inhaler-to-nebulizer initiative.
  • Demonstrate how to use a metered dose inhaler (MDI) and a spacer.
  • Demonstrate how to use an autoinjector.

Pharmacy Law Learning Objectives:

  • Describe the key provisions of Rhode Island’s recently enacted Tech Check Teck legislation and the advocacy efforts that led to its passage.
  • Assess the potential impact of Tech Check Tech on pharmacy workflow, pharmacist workload, and patient safety within their own practice environments.
  • Describe operational and clinical changes to pharmacy practice as a result of new legislation.
  • Describe how a technician’s role within a health-system pharmacy can be changed as a result of new legislation.
  • Describe one new business item that was approved at the 2025 House of Delegates meeting.
  • Describe two policies that were approved at the 2025 House of Delegates meeting.
  • Describe the key components and the purpose of the 340B Drug Pricing Program and the Inflation Reduction Act’s Maximum Fair Price provisions.

Patient Safety Learning Objectives:

  • Describe the distinct and overlapping responsibilities of pharmacists and pharmacy technicians.
  • Discuss best practices and tools for obtaining and verifying a complete, accurate medication list during admission and discharge.
  • Explain the importance of antibiotic stability with extended-infusions.
  • Explain how to evaluate patient outcomes related to insulin infusion-related protocol changes in the critical care setting.
  • Recognize common types of medication errors that may occur at discharge.
  • Demonstrate technician responsibilities that support accurate medication reconciliation.
  • Explain how to assist pharmacists and the healthcare team in implementing processes that reduce discharge-related medication errors.


A Special Thank You to Our Sponsors

Platinum 
 


 Gold
                   


Silver 
        

    For website issues issues, please click here

    Powered by Wild Apricot Membership Software